Search results :

Gefitinib

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: L01XE02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5
Diarrhoea very common, 0% - 66.7% x x x x x
Gastrointestinal disorder very common, 32.7% x x x
Mediastinal disorder common, 28.2% x x x
Rash very common, 0% - 68.9% x x x x x
Malnutrition very common x x x
Hepatobiliary disease very common x x
Dry skin very common, 0% - 29.2% x x x x x
Nausea rare — 0% - 23.6% x x x x x
Unspecified disorder of skin and subcutaneous tissue very common, 4.6% x x x
Acne 0% - 32.5% x x
Urinary tract disorder common, 12.8% x x x
Vomiting rare — 0% - 19.8% x x x x x
Alanine aminotransferase increased 0.98% - 23.6% x x
Stomatitis 0% - 8% x x x x
Feeling sick rare, very common x
Anorexia 0% - 18.9% x x x x x
Aspartate aminotransferase increased 0.98% - 22.6% x x
Pruritus common — 0% - 35.8% x x x x x
Alopecia common, 1-10% x x x x
Dehydration common x x x x
Eye disorder common x x
Body temperature increased common x x x x
Haemoptysis common x
Haemorrhage common x
Gastric ulcer common x
Dry mouth common x x x
Tenderness common x
Eye redness common x
Dry eye common x x x
Sore mouth common x
Appetite absent common x
Angiopathy common, 4.8% x x x
Nervous system disorder 4.5% x
Pain rare, 0.877% - 16% x x
Haematuria 0% - 6% x x x x x
Blepharitis 0.877% - 5.66% x x x x
Abdominal pain 2.91% - 7.55% x x
Asthenia common, 0% - 10.4% x x x x x
Weight decreased 1.94% - 5.66% x x x
Nail disorder 0% - 8.49% x x x x
Conjunctivitis 0.98% - 9.43% x x x x x
Amblyopia 2% x
Oedema peripheral 2% x x x
Epistaxis common, 0% - 11.3% x x x x x
Dermatitis exfoliative 0% - 8.49% x x
Interstitial lung disease 0.3 -2% - 1.3% x x x x x
Mouth ulceration 1% x x
Vesiculobullous rash 1% x
Dyspnoea 0% - 3% x x x
Corneal erosion 1% x x x x x
Keratitis 0.12% x x
Erythema multiforme 0.1% x x x x x
Pancreatitis rare, 0.1% x x x x x
Necrolysis epidermal 0.1% x
Angioedema 0.01% x x x x x
Hypersensitivity very rare x x x x
Urticaria very rare, 0.01% x x x x x
Lip swelling very rare x
Nettle rash very rare x
Anaemia x
Arrhythmia x
Atrial fibrillation x x
Bundle branch block x x
Infection x
Constipation x x
Cough x x
Cystitis x
Dermatitis x
Toxic epidermal necrolysis x x x x
Fatigue x
Cardiac disorder x
Hepatitis x x x
Hypokalaemia x x
Hypoproteinaemia 0% - 3% x
Hypotension x
Ischaemia x
Melaena x
Paronychia x
Pleural effusion x
Pneumonia 0% - 3% x x
Proteinuria x x
Rectal disorder x x
Seborrhoeic dermatitis 0% - 5.83% x x
Shock 0% - 4% x
Stevens-Johnson syndrome x x x
Thrombocytopenia x x
Thrombophlebitis x
Ulcer x
Hepatic failure x x
Rash pustular x x x
Cystitis haemorrhagic x x
Scrotal oedema 0% - 3% x x
Gastrointestinal perforation x x
Pulmonary haemorrhage 0% - 4% x
Hypomagnesaemia x
Eye pain x
Electrocardiogram QT prolonged x
Interstitial pneumonia 0% - 3% x x
Fatal outcomes x x x
Skin fissures x x
Hypoxia 0% - 3% x
Cutaneous vasculitis x x
Eruption x
Sinoatrial node dysfunction x
Alveolitis x
Cancer pain x
Drug interaction x
Febrile neutropenia x
Infestation NOS x
Blood and lymphatic system disorders x
Bullous conditions x x
Electrocardiogram QT corrected interval prolonged x
Pulmonary toxicity x
Respiratory failure x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

GEFITINIB

Side effects:36
Source:FDA Structured Product Label

gefitinib / gefitinib

Side effects:48
Source:EMA

Gefitinib

Side effects:44
Source:BC Cancer

GEFITINIB / IRESSA

Side effects:89
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label